Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| ENOV | Enovis CORP | 2025-10-16 16:26:58 | 31.64 | 0.45 | 1.44 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENOV | 0001420800 | Enovis CORP | US1940145022 | 635400OP2DYYYMOIYL17 | 541887631 | NYSE | 3842 | Orthopedic, Prosthetic & Surgical Appliances & Supplies | 1231 | DE | 2711 CENTERVILLE ROAD | WILMINGTON | DE | 19808 | UNITED STATES | US | (302) 252-9160 | 2711 CENTERVILLE ROAD, WILMINGTON, DE, 19808 | 2711 CENTERVILLE ROAD, WILMINGTON, DE, 19808 | Colfax CORP | Medical technology | 1995 | Matthew Trerotola | 5,000 | http://enovis.com | 2,460,000,000 | 57,159,478 | 57,159,803 | Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world. | 2025-10-10 20:51:57 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 2,460,000,000 | -1,018,000,000 | -29.2697 | 56,963,440 | 2,343,618 | 4.2908 |
| 2023 | 3,478,000,000 | 795,000,000 | 29.631 | 54,619,822 | 294,607 | 0.5423 |
| 2022 | 2,683,000,000 | -3,184,000,000 | -54.2696 | 54,325,215 | -107,005,177 | -66.3267 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Daniel A. Pryor | Executive Vice President | 2024 | 594,750 | 0 | 2,380,427 | 438,480 | 98,094 | 3,511,751 |
| Patricia Lang | Chief Human Resources Officer, Senior Vice President | 2024 | 492,500 | 0 | 1,403,804 | 331,601 | 72,240 | 2,300,144 |
| Matthew L. Trerotola | Chief Executive Officer | 2024 | 1,077,000 | 0 | 9,521,707 | 1,171,238 | 682,693 | 12,452,638 |
| Phillip “Ben | Chief Financial Officer | 2024 | 586,250 | 0 | 2,441,410 | 375,351 | 27,118 | 3,430,129 |
| Bradley J. Tandy | Chief Legal Officer, Senior Vice President | 2024 | 492,500 | 0 | 1,220,705 | 308,901 | 72,953 | 2,095,150 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 7,367 |
| 2023 | 6,550 |
| 2022 | 6,800 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 2,107,623,000 | 1,707,197,000 | 1,563,101,000 |
| Cost Of Revenue | 926,867,000 | 716,418,000 | 693,718,000 |
| Gross Profit | 1,180,756,000 | 990,779,000 | 869,383,000 |
| Research And Development Expenses | 91,298,000 | 75,331,000 | 60,827,000 |
| General And Administrative Expenses | 1,027,354,000 | 830,305,000 | 772,913,000 |
| Operating Expenses | — | — | — |
| Operating Income | -775,719,000 | -65,709,000 | -71,178,000 |
| Net Income | -825,494,000 | -33,261,000 | -13,292,000 |
| Earnings Per Share Basic | -14.93 | -0.61 | -0.25 |
| Earnings Per Share Diluted | -14.93 | -0.61 | -0.25 |
| Weighted Average Shares Outstanding Basic | 55,280,647 | 54,494,823 | 54,065,420 |
| Weighted Average Shares Outstanding Diluted | 55,280,647 | 54,494,823 | 54,065,420 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 48,167,000 | 36,191,000 | 24,295,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 407,031,000 | 291,483,000 | 267,380,000 |
| Inventories | 547,120,000 | 468,832,000 | 426,643,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 107,882,000 | 71,112,000 | 48,155,000 |
| Total Assets Current | 1,146,446,000 | 896,519,000 | 795,023,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 404,500,000 | 270,798,000 | 236,741,000 |
| Other Assets Non Current | 88,778,000 | 90,255,000 | 80,288,000 |
| Total Assets Non Current | 3,572,331,000 | 3,612,815,000 | 3,478,225,000 |
| Total Assets | 4,718,777,000 | 4,509,334,000 | 4,273,248,000 |
| Accounts Payable | 179,098,000 | 132,475,000 | 135,628,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 20,027,000 | 0 | 219,279,000 |
| Other Liabilities Current | 329,873,000 | 237,132,000 | 210,292,000 |
| Total Liabilities Current | 528,998,000 | 369,607,000 | 565,199,000 |
| Long Term Debt | 1,329,500,000 | 466,164,000 | 259,279,000 |
| Other Liabilities Non Current | 263,516,000 | 204,178,000 | 166,989,000 |
| Total Liabilities Non Current | 1,625,450,000 | 719,026,000 | 258,248,000 |
| Total Liabilities | 2,154,448,000 | 1,088,633,000 | 823,447,000 |
| Common Stock | 56,000 | 55,000 | 54,000 |
| Retained Earnings | -283,023,000 | 542,471,000 | 575,732,000 |
| Accumulated Other Comprehensive Income | -127,892,000 | -24,881,000 | -53,430,000 |
| Total Shareholders Equity | 2,562,262,000 | 3,418,392,000 | 3,448,085,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 284,796,000 | 217,109,000 | 219,710,000 |
| Share Based Compensation Expense | 29,662,000 | 34,065,000 | 38,955,000 |
| Other Non Cash Income Expense | -1,218,000 | 14,539,000 | -352,000 |
| Change In Accounts Receivable | 57,051,000 | 16,316,000 | 45,189,000 |
| Change In Inventories | -39,071,000 | 24,737,000 | 118,791,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 13,982,000 | -6,638,000 | -11,843,000 |
| Change In Other Liabilities | 9,931,000 | -20,423,000 | 46,464,000 |
| Cash From Operating Activities | 113,504,000 | 134,988,000 | -55,861,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 180,714,000 | 122,223,000 | 99,547,000 |
| Acquisition Of Business | 769,914,000 | 152,815,000 | 73,684,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -955,473,000 | -242,467,000 | -176,388,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 1,874,000 | 1,776,000 | 5,814,000 |
| Repurchase Of Common Stock | 4,772,000 | 0 | 0 |
| Issuance Of Long Term Debt | 992,000,000 | 455,000,000 | — |
| Repayment Of Long Term Debt | 20,000,000 | 219,468,000 | 634,883,000 |
| Other Financing Activities | -8,805,000 | -3,536,000 | -7,507,000 |
| Cash From Financing Activities | 846,821,000 | 127,797,000 | -465,127,000 |
| Change In Cash | 3,335,000 | 20,537,000 | -695,075,000 |
| Cash At End Of Period | 48,167,000 | 36,191,000 | 24,295,000 |
| Income Taxes Paid | 10,798,000 | 12,515,000 | 31,360,000 |
| Interest Paid | 51,826,000 | 16,328,000 | 37,089,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | -14.93 | -0.61 | -0.25 |
| Price To Earnings Ratio | -2.939 | -91.8361 | -214.08 |
| Earnings Growth Rate | 2,347.541 | 144 | -153.1915 |
| Price Earnings To Growth Ratio | -0.0013 | -0.6378 | 1.3975 |
| Book Value Per Share | 46.3875 | 62.7711 | 63.8079 |
| Price To Book Ratio | 0.9459 | 0.8924 | 0.8388 |
| Ebitda | -472,800,000 | 216,112,000 | 261,830,000 |
| Enterprise Value | 3,727,074,790.36 | 3,482,772,984.46 | 3,347,844,278.4 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.5267 | 0.1364 | 0.1388 |
| Capital Expenditures | 418,498,000 | 251,166,000 | -64,940,000 |
| Free Cash Flow | -304,994,000 | -116,178,000 | 9,079,000 |
| Return On Equity | -0.3222 | -0.0097 | -0.0039 |
| One Year Beta | 1.2003 | 1.1212 | 1.197 |
| Three Year Beta | 1.182 | 1.1688 | 1.4891 |
| Five Year Beta | 1.4381 | 1.4734 | 1.46 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Lalor Angela S | Director | 2025-09-30 | 742 | A | 21,295 |
| McDonald Damien | Director, Chief Executive Officer | 2025-09-11 | 6,457 | A | 102,753 |
| Tandy Bradley J | SVP and Chief Legal Officer | 2025-08-22 | 3,200 | A | 43,515 |
| BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | 2025-08-20 | 2,500 | A | 116,729 |
| PRYOR DANIEL A | EVP, Strategy & Business Dev. | 2025-08-13 | 10,000 | A | 161,115 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Portman Square Capital LLP | 2025-09-30 | 5,169,936 | 170,400 | 30.34 |
| Portman Square Capital LLP | 2025-09-30 | 11,435,146 | 376,900 | 30.34 |
| HALBERT HARGROVE GLOBAL ADVISORS, LLC | 2025-09-30 | 365 | 12 | 30.4167 |
| CWM, LLC | 2025-09-30 | 36,000 | 1,188 | 30.303 |
| PRIVATE TRUST CO NA | 2025-09-30 | 14,229 | 469 | 30.339 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Small Cap Fund | CFSLX | 33,921 | 1,048,158.9 | 0.2188 |
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Small Cap Select Fund | CFSSX | 367,649 | 11,360,354.1 | 0.7908 |
| RUSSELL INVESTMENT CO | 2025-07-31 | Class Y | REBYX | 27,154 | 727,727.2 | 0.1166 |
| NUVEEN INVESTMENT FUNDS INC | 2025-07-31 | Class R6 | FSCWX | 52,491 | 1,406,758.8 | 0.5244 |
| NUVEEN INVESTMENT FUNDS INC | 2025-07-31 | Class I | FSCCX | 52,491 | 1,406,758.8 | 0.5244 |